Table 2.
Biomarker | AUC | 95% CI | p value | p value (comparison with galectin-3 AUC) |
---|---|---|---|---|
Galectin-3 | 0.75 | (0.67–0.84) | < 0.0001 | – |
CRP | 0.76 | (0.68–0.85) | < 0.0001 | 0.70 |
Albumin | 0.73 | (0.65–0.82) | < 0.0001 | 0.93 |
NLR | 0.71 | (0.62–0.79) | < 0.0001 | 0.52 |
Neutrophil count | 0.70 | (0.61–0.78) | < 0.0001 | 0.43 |
Ferritin | 0.66 | (0.57–0.76) | < 0.01 | 0.19 |
Lymphocyte count | 0.58 | (0.49–0.68) | 0.09 | 0.02 |
Platelets | 0.48 | (0.38–0.58) | 0.66 | < 0.01 |
D-Dimer | 0.69 | (0.60–0.79) | < 0.001 | 0.49 |
Fibrinogen | 0.66 | (0.57–0.75) | < 0.01 | 0.16 |
INR | 0.61 | (0.51–0.71) | 0.04 | 0.05 |
Triglycerides | 0.64 | (0.54–0.74) | 0.01 | 0.12 |
AST | 0.68 | (0.59–0.76) | < 0.001 | 0.27 |
ROC curves were performed to determine the discrimination power of each biomarker for severe outcome. The AUC obtained was compared against that of galectin-3 using DeLong’s test for correlated ROC curves. Bold values represent p < 0.05.